My bad, I shouldn't have used that word. It should have been exchanged or something else rather than sold, I misspoke. The Hartindo rights were bought from PCL (not MGON or Gardner individually) and the MEVT shares (the purchasing price for the rights) were given to PCL, not Joel Gardner individually or MGON.
What is interesting is that MGON was involved in this deal (but weren't the ones the rights were purchased from, that was PCL) because MGON already owned non-exclusive rights to distribute Hartindo in the United States (and exclusive in the rest of North America).
What is really interesting is that the so called "exclusive" rights (which is how it was termed in the contract) which were sold to MEVT weren't actually exclusive. This is because the contract also said that the previous deal between PCL and MGON (where MGON could distribute Hartindo in the United States non-exclusively) would still stand as long as it did not interfere with MEVT's rights to distribute the Hartindo product in the United States. If you ask me, that makes no sense at all because then MEVT's rights weren't actually exclusive from the very beginning and they knew it. It is very confusing and a horribly drawn up contract because it is very unclear. Here's the link (below) to the original Trilateral Agreement between MGON, MEVT, and PCL (which was in the EPRO 10k, just scroll down to Exhibits A and B and make sure you read the ENTIRETY of both exhibits).
It's also interesting that in the contract it says that the contract will not be made publicly available without the written consent of MGON and MEVT..... I wonder if MEVT (or EPRO) ever got the written consent from MGON to make this thing publicly available a couple months ago...... highly doubtful.
Market Data 
Markets 
AI
